Eight additional national and regional health plans are now covering ZORYVE for plaque psoriasis ZORYVE…
Eight additional national and regional health plans are now covering ZORYVE for plaque psoriasis ZORYVE…
Rajavelu to continue supporting Fulcrum in a consulting capacity CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE)…
Rajavelu to continue supporting Fulcrum in a consulting capacity CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE)…
Significant reduction of toxic protein aggregate, Poly(GP) Significant increase in biomarker of target engagement, sGPNMB…
Significant reduction of toxic protein aggregate, Poly(GP) Significant increase in biomarker of target engagement, sGPNMB…
LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
LEXINGTON, Mass., April 05, 2023 (GLOBE NEWSWIRE) — T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the…
U.S. sales of Macrilen®for adult use to be temporarily discontinued as of May 23, 2023,…
U.S. sales of Macrilen®for adult use to be temporarily discontinued as of May 23, 2023,…
Company Recognized for Positive Vaccine Expertise Contributions MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) —…
Company Recognized for Positive Vaccine Expertise Contributions MORRISVILLE, N.C., April 05, 2023 (GLOBE NEWSWIRE) —…
Parties add several deliverables to initial R&D collaboration contract Overall potential revenue increased to up…
Parties add several deliverables to initial R&D collaboration contract Overall potential revenue increased to up…
DEVON, Pa., April 05, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
DEVON, Pa., April 05, 2023 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company…
CAMBRIDGE, Mass., April 05, 2023 (GLOBE NEWSWIRE) — Generation Bio Co. (Nasdaq:GBIO), a biotechnology company…
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Endogena Therapeutics…
SAN FRANCISCO and TORONTO and ZÜRICH, Switzerland, April 05, 2023 (GLOBE NEWSWIRE) — Endogena Therapeutics…